The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/be/e8/41/bee8419d-cc9c-5ffd-230b-7e8ccadcbd19/mza_7352749994225335026.jpg/600x600bb.jpg

The Cancer Letter

52 episodes

4 days ago

The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973. With a dedicated audience of oncology’s leaders, The Cancer Letter stays on top of breaking news and advances in oncology, providing authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health. This weekly podcast features interviews, discussions, and more to dig deep into the issues that shape oncology.

Medicine

Health & Fitness

RSS

All content for The Cancer Letter is the property of The Cancer Letter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/42790382/42790382-1762535585676-3fb7bad7c3a6c.jpg

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery

The Cancer Letter

58 minutes 57 seconds

1 week ago

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.

“I was born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of my training in England, in the United Kingdom,” Odunsi said. “My residency in obstetrics and gynecology was at Yale School of Medicine, so it was a very welcoming environment.

“In fact, many of us in my class, four out of six, were international graduates, because Yale had the philosophy at the time that we’re just going to take the best from wherever, and that was my experience. I felt just as good as anyone else. It was a great time.”

Ruben Mesa, president of Advocate Health Center Cancer Service Line, is the child of Cuban refugees and agreed with Odunsi that international collaboration is vital for a healthy research ecosystem.

“I trained at Mayo Clinic, and when I was a resident and fellow, I think about some of the extraordinary individuals, folks like Kunle, again, who came and had trained from other countries, but were just exceptional individuals and really moved forward the science and brought tremendous skills also from their medical training,” Mesa said.

As part of its crackdown on immigration under the Trump administration, the U.S. Citizen and Immigration Services announced that as of Sept. 21, H-1B visa petitions will require a $100,000 fee in an attempt to “curb abuses and protect American workers.”

“For someone like myself, I don’t think Yale would’ve paid $100,000 to get me an H-1B visa at the time, and I’m sure it’s going to be hard,” Odunsi, who is also the director of the Comprehensive Cancer Research Center, the AbbVie Foundation Distinguished Service Professor of Obstetrics and Gynecology, and dean for oncology at University of Chicago Medicine, said. “But as I said, and as you pointed out, we have to keep our eyes on the target, on our target, and that is cancer.”

A transcript of this episode is available: https://cancerletter.com/podcastc/20251107_1/